Skip to content

DBT in Borderline Personality Disorder

Dialectical Behavioral Therapy for Patients With Borderline Personality Disorder

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00252031
Enrollment
Unknown
Registered
2005-11-11
Start date
Unknown
Completion date
Unknown
Last updated
2005-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Borderline Personality Disorder

Keywords

Borderline Personality Disorder, BPD, Dialectical Behavior Therapy, DBT

Brief summary

Subjects will receive a 6-month course of DBT, consisting of one 90-minute group and one 60-minute individual session per week as well as telephone availability of the individual therapist.

Interventions

Sponsors

Bronx VA Medical Center
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

Is a male or female between 18 and 60 who meets criteria for Borderline Personality Disorder and has had at least 2 prior instances of suicidal or parasuicidal behavior. Either is off psychotropic drugs or is on a stable medication regimen. (During the study, psychotropic medications will be prescribed by a psychiatrist in the Mood and Personality Disorders Group.)

Exclusion criteria

Meets criteria for Schizophrenia, Bipolar Disorder, Mental Retardation or current or recent Substance Dependence. Subjects also should not currently be in individual psychotherapy. (Case management and work therapy programs are allowed.)

Design outcomes

Primary

MeasureTime frame
Measures of parasuicidal behavior, suicidal ideation, mood and emotion, dissociation and health care utilization at baseline, 3 months, 6 months and 9 months

Secondary

MeasureTime frame
Measures of cognitive processing at baseline and 6 months

Countries

United States

Contacts

Primary ContactEmily Hart
mpgroup@mssm.edu212-241-0441

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026